Matthew Harrison
Stock Analyst at Benchmark
(3.24)
# 1,062
Out of 4,761 analysts
731
Total ratings
46.65%
Success rate
1.95%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LYV Live Nation Entertainment | Maintains: Buy | $160 → $178 | $149.40 | +19.14% | 1 | Feb 21, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $192 → $157 | $140.64 | +11.63% | 51 | Feb 13, 2025 | |
| GILD Gilead Sciences | Maintains: Overweight | $113 → $123 | $109.95 | +11.87% | 39 | Feb 12, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Equal-Weight | $450 → $459 | $484.24 | -5.21% | 37 | Feb 11, 2025 | |
| INSM Insmed | Maintains: Overweight | $85 → $90 | $81.06 | +11.03% | 16 | Feb 6, 2025 | |
| CMCSA Comcast | Maintains: Buy | $57 → $55 | $36.24 | +51.77% | 2 | Jan 31, 2025 | |
| MRNA Moderna | Maintains: Equal-Weight | $70 → $38 | $35.53 | +6.95% | 24 | Jan 15, 2025 | |
| ALEC Alector | Downgrades: Underweight | $10 → $3 | $1.87 | +60.43% | 10 | Nov 26, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Overweight | $1,235 → $1,184 | $700.33 | +69.06% | 50 | Nov 1, 2024 | |
| AVNT Avient | Downgrades: Neutral | n/a | $43.40 | - | 1 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $4 → $6 | $1.10 | +445.45% | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $2 → $6.88 | $3.09 | +122.65% | 9 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $6 | $2.61 | +129.89% | 9 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $165 → $200 | $106.28 | +88.18% | 34 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $16.63 | -33.85% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $38 → $8 | $2.32 | +244.83% | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $510 | $644.48 | -20.87% | 24 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $1.92 | +264.58% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $112 | $68.25 | +64.10% | 21 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 | $16.49 | +106.19% | 14 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $22.34 | +43.24% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $2.97 | +540.81% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $14 | $1.11 | +1,161.26% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $65 → $85 | $39.70 | +114.11% | 10 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underweight | $60 | $4.08 | +1,370.59% | 30 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $61 → $63 | $20.73 | +203.91% | 11 | Apr 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $13 | $3.03 | +329.04% | 4 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $1.77 | -43.50% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $18.08 | -44.69% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $3.85 | +107.79% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $26.74 | +64.55% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $3.01 | +331.89% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $4 | $0.70 | +470.86% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $5 → $3 | $0.49 | +514.75% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $120.01 | +79.99% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $1.63 | +206.75% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $2.06 | +142.72% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $202.08 | -9.94% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $4.45 | +102.25% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $40 | $51.84 | -22.84% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $303.01 | -6.93% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $250.59 | -16.20% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $736 → $621 | $9.63 | +6,348.60% | 7 | Sep 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $26.30 | +97.72% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $162.30 | +6.59% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $61 → $57 | $7.31 | +679.75% | 9 | Mar 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $42.59 | +181.76% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $36.91 | +300.98% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $89.50 | -8.38% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $55.83 | +18.22% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $1.61 | +2,322.36% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $33.42 | +37.64% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $15.49 | +125.95% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $873.68 | -68.52% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $1.94 | +879.38% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $7.27 | +752.82% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $16.15 | +6.81% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $50 | $1.94 | +2,477.32% | 4 | Aug 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $72.11 | +15.10% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $59 → $57 | $13.17 | +332.80% | 4 | Oct 11, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $50.26 | -80.10% | 4 | Sep 10, 2018 |
Live Nation Entertainment
Feb 21, 2025
Maintains: Buy
Price Target: $160 → $178
Current: $149.40
Upside: +19.14%
Biogen
Feb 13, 2025
Maintains: Equal-Weight
Price Target: $192 → $157
Current: $140.64
Upside: +11.63%
Gilead Sciences
Feb 12, 2025
Maintains: Overweight
Price Target: $113 → $123
Current: $109.95
Upside: +11.87%
Vertex Pharmaceuticals
Feb 11, 2025
Maintains: Equal-Weight
Price Target: $450 → $459
Current: $484.24
Upside: -5.21%
Insmed
Feb 6, 2025
Maintains: Overweight
Price Target: $85 → $90
Current: $81.06
Upside: +11.03%
Comcast
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $36.24
Upside: +51.77%
Moderna
Jan 15, 2025
Maintains: Equal-Weight
Price Target: $70 → $38
Current: $35.53
Upside: +6.95%
Alector
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $1.87
Upside: +60.43%
Regeneron Pharmaceuticals
Nov 1, 2024
Maintains: Overweight
Price Target: $1,235 → $1,184
Current: $700.33
Upside: +69.06%
Avient
Oct 18, 2024
Downgrades: Neutral
Price Target: n/a
Current: $43.40
Upside: -
Sep 16, 2024
Maintains: Overweight
Price Target: $4 → $6
Current: $1.10
Upside: +445.45%
Aug 13, 2024
Upgrades: Equal-Weight
Price Target: $2 → $6.88
Current: $3.09
Upside: +122.65%
Jul 29, 2024
Maintains: Equal-Weight
Price Target: $7 → $6
Current: $2.61
Upside: +129.89%
Jun 24, 2024
Maintains: Overweight
Price Target: $165 → $200
Current: $106.28
Upside: +88.18%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $16.63
Upside: -33.85%
Jun 18, 2024
Downgrades: Equal-Weight
Price Target: $38 → $8
Current: $2.32
Upside: +244.83%
May 28, 2024
Maintains: Overweight
Price Target: $515 → $510
Current: $644.48
Upside: -20.87%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $1.92
Upside: +264.58%
Apr 26, 2024
Maintains: Overweight
Price Target: $115 → $112
Current: $68.25
Upside: +64.10%
Apr 22, 2024
Maintains: Overweight
Price Target: $34
Current: $16.49
Upside: +106.19%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $22.34
Upside: +43.24%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $2.97
Upside: +540.81%
Aug 10, 2023
Maintains: Overweight
Price Target: $13 → $14
Current: $1.11
Upside: +1,161.26%
Jul 20, 2023
Maintains: Overweight
Price Target: $65 → $85
Current: $39.70
Upside: +114.11%
Jul 11, 2023
Reiterates: Underweight
Price Target: $60
Current: $4.08
Upside: +1,370.59%
Apr 12, 2023
Maintains: Overweight
Price Target: $61 → $63
Current: $20.73
Upside: +203.91%
Mar 27, 2023
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $3.03
Upside: +329.04%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $1.77
Upside: -43.50%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $18.08
Upside: -44.69%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $3.85
Upside: +107.79%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $26.74
Upside: +64.55%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $3.01
Upside: +331.89%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $4
Current: $0.70
Upside: +470.86%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $5 → $3
Current: $0.49
Upside: +514.75%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $120.01
Upside: +79.99%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $1.63
Upside: +206.75%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $2.06
Upside: +142.72%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $202.08
Upside: -9.94%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $4.45
Upside: +102.25%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30 → $40
Current: $51.84
Upside: -22.84%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $303.01
Upside: -6.93%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $250.59
Upside: -16.20%
Sep 9, 2022
Maintains: Overweight
Price Target: $736 → $621
Current: $9.63
Upside: +6,348.60%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $26.30
Upside: +97.72%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $162.30
Upside: +6.59%
Mar 10, 2022
Maintains: Equal-Weight
Price Target: $61 → $57
Current: $7.31
Upside: +679.75%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $42.59
Upside: +181.76%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $36.91
Upside: +300.98%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $89.50
Upside: -8.38%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $55.83
Upside: +18.22%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $1.61
Upside: +2,322.36%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $33.42
Upside: +37.64%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $15.49
Upside: +125.95%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $873.68
Upside: -68.52%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $1.94
Upside: +879.38%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $7.27
Upside: +752.82%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $16.15
Upside: +6.81%
Aug 18, 2020
Downgrades: Equal-Weight
Price Target: $50
Current: $1.94
Upside: +2,477.32%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $72.11
Upside: +15.10%
Oct 11, 2018
Maintains: Overweight
Price Target: $59 → $57
Current: $13.17
Upside: +332.80%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $50.26
Upside: -80.10%